Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617F

Polycythemia vera (PV) is a chronic myeloproliferative neoplasm that is associated with a substantial symptom burden, thrombohemorrhagic complications, and impaired survival. A decade after the seminal discovery of an activating mutation in the tyrosine kinase JAK2 in nearly all patients with PV, ne...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Oncol
Autors principals: Stein, Brady L., Oh, Stephen T., Berenzon, Dmitriy, Hobbs, Gabriela S., Kremyanskaya, Marina, Rampal, Raajit K., Abboud, Camille N., Adler, Kenneth, Heaney, Mark L., Jabbour, Elias J., Komrokji, Rami S., Moliterno, Alison R., Ritchie, Ellen K., Rice, Lawrence, Mascarenhas, John, Hoffman, Ronald
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2015
Matèries:
Review Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4979103/
https://ncbi.nlm.nih.gov/pubmed/26324368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.61.6474
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars